Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2015
Dec. 31, 2014
Assets    
Financing receivables $ 783,967 $ 552,706
Financing receivables held-for-sale 60,376 62,275
Investments available-for-sale 29,017 27,273
Real estate 128,769 90,907
Real estate related intangible assets 26,930 23,058
Equity method investments in affiliates 318,769 143,903
Cash and cash equivalents 42,645 58,199
Other assets 79,148 50,361
Total Assets 1,469,621 1,008,682
Liabilities:    
Accounts payable, accrued expenses and other 17,875 11,408
Deferred funding obligations 108,499 88,288
Credit facility 247,350 315,748
Asset-backed nonrecourse debt (secured by assets of $718 million and $248 million, respectively) 563,189 206,671
Other nonrecourse debt (secured by financing receivables of $97 million and $108 million, respectively) 100,602 112,525
Total Liabilities $ 1,037,515 $ 734,640
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 37,010,603 and 26,377,111 shares issued and outstanding, respectively $ 370 $ 264
Additional paid in capital 482,431 293,635
Retained deficit (52,701) (25,006)
Accumulated other comprehensive (loss) income (1,905) 406
Non-controlling interest 3,911 4,743
Total Stockholders' Equity 432,106 274,042
Total Liabilities and Stockholders' Equity $ 1,469,621 $ 1,008,682